FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Medaus M.I.C B-Complex W/Pres. Recall

M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG;…

Medaus, Inc. · Birmingham, AL

Risk level
Class II
Reported by FDA
Jul 20, 2016
Recall ID
D-1223-2016
Check your lot numberHow we source this data

Summary

Medaus recalled M.I.C B-Complex W/Pres. starting May 13, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1223-2016 on Jul 20, 2016. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-50MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY

Lot numbers, UPCs & expiration codes

Lot #: 160119-59; BUD: 05/26/16, Lot #: 151228-72; BUD: 05/26/16, Lot #: 160127-4; BUD: 05/26/16, Lot #: 160201-13; BUD: 05/26/16, Lot #: 160202-13; BUD: 05/26/16, Lot #: 160204-11; BUD: 05/26/16, Lot #: 160202-66; BUD: 06/11/16, Lot #: 160307-31; BUD: 06/11/16, Lot #: 160224-68; BUD: 06/11/16, Lot #: 160205-8; BUD: 06/11/16

Where it was sold

U.S. Nationwide, Japan, and New Zealand.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1223-2016
Classification
Class II
Status
Terminated
Recall initiated
May 13, 2016
FDA report date
Jul 20, 2016
Quantity
1430 mL in Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Medaus, Inc.

Original FDA data

Every field from FDA enforcement report D-1223-2016, exactly as published.

Show all FDA fields
City
Birmingham
State
AL
Status
Terminated
Country
United States
Event ID
74466
Address
6801 Cahaba Valley Rd Ste 116
Code information
Lot #: 160119-59; BUD: 05/26/16, Lot #: 151228-72; BUD: 05/26/16, Lot #: 160127-4; BUD: 05/26/16, Lot #: 160201-13; BUD: 05/26/16, Lot #: 160202-13; BUD: 05/26/16, Lot #: 160204-11; BUD: 05/26/16, Lot #: 160202-66; BUD: 06/11/16, Lot #: 160307-31; BUD: 06/11/16, Lot #: 160224-68; BUD: 06/11/16, Lot #: 160205-8; BUD: 06/11/16
Postal code
35242-9609
Report date
Jul 20, 2016
Product type
Drugs
Recall number
D-1223-2016
Classification
Class II
Recalling firm
Medaus, Inc.
Product quantity
1430 mL in Vials
Termination date
Jun 16, 2017
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-50MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY
Distribution pattern
U.S. Nationwide, Japan, and New Zealand.
Recall initiation date
May 13, 2016
Initial firm notification
E-Mail
Center classification date
Jul 8, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1223-2016, published Jul 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls